{
  "chapter": "Acute Myeloid Leukemia  AML",
  "questions": [
    {
      "q_no": 1,
      "question": "Question 1: Which of the following is not a myeloid marker?",
      "options": {
        "a": "CD64",
        "b": "CD3",
        "c": "CD11b",
        "d": "CD117"
      },
      "correct_answer": "b",
      "explanation": "CD3 is not a myeloid marker. It is a T-cell lymphoid marker. Cell markers: 474 \nSold by @itachibot • B-cell: CD10, CD19, CD20, CD22, CD23, CD24, CD79b, CD103, Pax-5, kappa, lambda, CD200, \ncytoplasmic kappa, cytoplasmic lambda • T- cell: CD1, CD2, CD3, CD4, CD5, CD6,CD7, CD8, TCR apha-beta, TCR gamma-delta, \ncytoplasmic CD3 • Myeloid: CD11b, CD13, CD14, CD15, CD33, CD64, CD 117, myeloperoxidase",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 2,
      "question": "Question 2: Which of the following is the most common type of acute myeloid leukemia?",
      "options": {
        "a": "AML M1",
        "b": "AML M2",
        "c": "AML M3",
        "d": "AML M7"
      },
      "correct_answer": "b",
      "explanation": "The most common type of acute myeloid leukemia (AML) is AML - M2 or AML with maturation. The least common type of AML is AML M7 or megakaryocytic.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 3,
      "question": "Question 3: What is the most common subtype of acute myeloid leukemia seen in patients with Down's \nsyndrome?",
      "options": {
        "a": "AML M3",
        "b": "AML M4",
        "c": "AML M6",
        "d": "AML M7"
      },
      "correct_answer": "d",
      "explanation": "The most common subtype of AML seen in Down's syndrome is acute myeloid leukemia-M7 (AML \n- M7) or acute megakaryocytic leukemia. Myeloid proliferations of Down's syndrome are usually megakaryoblastic. It includes: • Transient abnormal myelopoiesis (TAM) - occurs at birth or within days of birth and resolves in 1 \nto 2 months • Myeloid leukemia associated with Down syndrome - occurs later, but usually in the first 3 years \nof life. Both are characterized by GATA1 mutations and mutations of the JAK-STAT pathway.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 4,
      "question": "Question 4: A 35-year-man presents with nosebleeds, bleeding gums, and multiple ecchymoses. Lab \ninvestigations show the following findings. The blasts are positive for CD33. What is the most \nlikely diagnosis? 467 \nSold by @itachibot",
      "options": {
        "a": "Acute myeloid leukemia",
        "b": "Acute lymphoblastic leukemia",
        "c": "Small Lymphocytic lymphoma",
        "d": "Myelodysplastic syndrome"
      },
      "correct_answer": "a",
      "explanation": "The given clinical scenario is suggestive of acute myeloid leukemia (AML). AML is a tumor of hematopoietic progenitors caused by acquired oncogenic mutations that \nimpede differentiation, leading to the accumulation of immature myeloid blasts in the marrow. It \noccurs at all ages, but the incidence rises throughout life, peaking after 60 years of age. The peripheral smear shows blasts with abundant cytoplasm, fine azurophilic granules, Auer rods, \nand delicate nuclear chromatin with 1-4 prominent nucleoli. The blasts are positive for \nCD33. Occasionally, blasts are entirely absent from the blood (aleukemic leukemia). Bone marrow \nexamination is essential to exclude acute leukemia in pancytopenic patients.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpathology/Acute_Myeloid_Leukemia__AML_Q4_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 5,
      "question": "Question 5: Peripheral smear of a patient with acute promyelocytic leukemia shows myeloblasts with the \nfollowing finding. What are these made of?",
      "options": {
        "a": "Lysosomes",
        "b": "Golgi apparatus",
        "c": "Endoplasmic reticulum",
        "d": "Ribosomes"
      },
      "correct_answer": "a",
      "explanation": "The image shows Auer rods in myeloblasts. These are needle-shaped azurophilic intracytoplasmic \ninclusion bodies formed by the fusion of lysosomes. 475 \nSold by @itachibot Auer rods contain peroxidase and lysosomal enzymes. Myeloblasts with bundles of Auer rods are \ncalled faggot cells and are seen in acute promyelocytic leukemia.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpathology/Acute_Myeloid_Leukemia__AML_Q5_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 6,
      "question": "Question 6: In which of the following conditions are Auer rods seen?",
      "options": {
        "a": "1 and 2 only",
        "b": "3, 4, and 5",
        "c": "1, 2, 3, 4, and 5",
        "d": "1, 3, and 4"
      },
      "correct_answer": "d",
      "explanation": "Auer rods are seen in: • Acute promyelocytic leukemia • Myelodysplastic syndromes • Chronic myelomonocytic leukemia These are not seen in acute monocytic leukemia and acute lymphoblastic leukemia.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 7,
      "question": "Question 7: A 20-year-old male patient is diagnosed with acute myeloid leukemia. The peripheral blood \nsmear picture is given in the image. The cell indicated by the arrow is best described as:",
      "options": {
        "a": "Auer rod",
        "b": "Flaming promyelocyte",
        "c": "Faggot cell",
        "d": "Dusky promyelocyte"
      },
      "correct_answer": "c",
      "explanation": "The given cell shows multiple Auer rods clustered together within a single cell resembling a \nbundle of sticks. Such cells have been termed as faggot cells (faggot in French means bundle of \nsticks). Since the question specifically asks about the cell, the best answer is faggot cell (not Auer rods). Option A: Auer rods are distinctive needle-like azurophilic granules present in many cases but \nparticularly numerous in AML with the t(15;17) aberration (acute promyelocytic leukemia). Option B: The term flaming promyelocyte refers to cells that appear to be breaking apart, taking \non a vibrant reddish-purple hue with the apparent liberation of granules into the surrounding \ncellular matrix. Option C: Promyelocytes containing fine granules appear dusky or hazy and are referred to as \ndusky promyelocytes.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpathology/Acute_Myeloid_Leukemia__AML_Q7_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 8,
      "question": "Question 8: Increased levels of serum muramidase are seen in patients with which of the following \nconditions?",
      "options": {
        "a": "Acute myeloid leukemia - M4",
        "b": "Acute myeloid leukemia - M2",
        "c": "Acute myeloid leukemia - M6",
        "d": "Acute myeloid leukemia - M3"
      },
      "correct_answer": "a",
      "explanation": "Serum muramidase or lysozyme levels are seen to be increased in patients with acute \nmyelomonocytic leukemia (AML - M4). It is also increased in chronic myelomonocytic leukemia and chronic myeloid leukemia (CML).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 9,
      "question": "Question 9: Which type of AML is known as Di Guglielmo disease?",
      "options": {
        "a": "Acute myeloid leukemia - M2",
        "b": "Acute myeloid leukemia - M5",
        "c": "Acute myeloid leukemia - M6",
        "d": "Acute myeloid leukemia - M7"
      },
      "correct_answer": "c",
      "explanation": "Acute myeloid leukemia-M6 (AML-M6) or acute erythroid leukemia is known as Di Guglielmo \ndisease. AML-M6 accounts for 1% of AML cases. It has two subtypes: 476 \nSold by @itachibot • Erythroid/myeloid leukemia (M6a, more common) - Dyserythropoiesis is prominent • Pure erythroid leukemia/ erythemic myelosis/ Di Guglielmo disease (M6b, rare) - &gt;80% \nerythroid precursors. Clinical findings include anemia, thrombocytopenia, and variable \nneutropenia. Positive stains for erythroid cells are glycophorin A, hemoglobin A, CD36, CD71, CD117, and PAS.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 10,
      "question": "Question 10: In patients with which of the following conditions, a dry tap may be seen on bone marrow \naspiration?",
      "options": {
        "a": "Burkitt lymphoma",
        "b": "Acute myeloid leukemia - M6",
        "c": "Acute myeloid leukemia - M7",
        "d": "Undifferentiated leukemia"
      },
      "correct_answer": "c",
      "explanation": "Acute megakaryocytic leukemia (AML M7) may yield a dry tap on marrow aspiration. It may be associated with extensive bone marrow fibrosis as a result of the stimulation of the \nnormal fibroblasts by the local secretion of platelet-derived growth factor (PDGF) by the leukemic \ncells.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 11,
      "question": "Question 11: Bone marrow aspirate of a patient diagnosed with acute myeloid leukemia shows the \npresence of faggot cells. What is the most likely subtype of acute myeloid leukemia, the \npatient is suffering from?",
      "options": {
        "a": "Acute myeloid leukemia - M5",
        "b": "Acute myeloid leukemia - M4",
        "c": "Acute myeloid leukemia - M3",
        "d": "Acute myeloid leukemia - M2"
      },
      "correct_answer": "c",
      "explanation": "The presence of faggot cells is highly suggestive of acute myeloid leukemia - M3 (AML - M3) or \nacute promyelocytic leukemia. A cluster of Auer rods is known as a faggot cell. It is characteristic of acute myeloid leukemia \n(AML) M3. The image given below shows AML M3 with a cluster of Auer rods (faggot cell).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 12,
      "question": "Question 12: A patient diagnosed with acute myeloid leukemia presents with a one-day history of bleeding \ngums, subconjunctival bleed, and purpuric rash. Investigations done are given below. Which \nof the following genetic abnormalities is most likely to be detected?",
      "options": {
        "a": "Inversion 16",
        "b": "t(8;21)",
        "c": "Inversion 3",
        "d": "t(15;17)"
      },
      "correct_answer": "d",
      "explanation": "477 \nSold by @itachibot The patient shows features of disseminated intravascular coagulation (DIC). It is most likely to be \nassociated with acute myeloid leukemia - M3 or acute promyelocytic leukemia. The pathogenesis \nbehind this is t(15,17) or PML-RARA fusion gene. Option A: Inversion 16 is seen in acute myelomonocytic leukemia or AML - M4. Option B: t(8;21) is seen in AML with differentiation or AML - M2. Option C: Inversion 3 is seen in AML - M7 (megakaryoblastic) which shows normal or increased \nplatelet count. It has a poor prognosis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 13,
      "question": "Question 13: Which type of acute myeloid leukemia is myeloperoxidase negative?",
      "options": {
        "a": "Acute myeloid leukemia - M0",
        "b": "Acute myeloid leukemia - M1",
        "c": "Acute myeloid leukemia - M2",
        "d": "Acute myeloid leukemia - M4"
      },
      "correct_answer": "a",
      "explanation": "AML M0 is negative for myeloperoxidase (MPO). AML-M5 (monocytic), AML-M6 (erythroid), and \nAML-M7 (megakaryocytic) are also negative for MPO. Myeloperoxidase (MPO) is located in the primary granules of neutrophils and their precursors, in \neosinophil granules, and in the azurophilic granules of monocytes. The most primitive myeloblasts are negative, with granular positivity appearing progressively as \nthey mature toward the promyelocyte stage. Promyelocytes and myelocytes are the most strongly \nstaining cells in the granulocyte series. Monoblasts and monocytes may be negative or positive. AML-M4 shows both myelocytic and monocytic differentiation. Hence, it shows both MPO and \nnon-specific esterase (marker for monocytes) positivity.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 14,
      "question": "Question 14: A patient with fatigue and recurrent infections undergoes bone marrow evaluation. It shows \n&gt; 20% myeloblasts, which stain positive for CD61. What is the likely diagnosis?",
      "options": {
        "a": "Acute promyelocytic leukemia",
        "b": "Acute megakaryocytic leukemia",
        "c": "Acute myelomonocytic leukemia",
        "d": "Acute monocytic leukemia"
      },
      "correct_answer": "b",
      "explanation": "The given clinical scenario with myeloblasts that stain positive for CD61 is suggestive of acute \nmegakaryocytic leukemia (AML-M7). AML M7 is the least common type of AML. Blasts of megakaryocytic lineage predominate and are \nassociated with marrow fibrosis. There is also frequent budding of cytoplasmic margins. They are CD41+ and CD61+. They stain negatively with Sudan black B (SBB) and myeloperoxidase \n(MPO). Blasts are reactive with PAS and acid phosphatase. The prognosis for this type of acute leukemia is poor.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 15,
      "question": "Question 15: A patient who developed the following lesions over the body was diagnosed with acute \nmyeloid leukemia. Which subtype of AML does this patient most likely have? 471 \nSold by @itachibot",
      "options": {
        "a": "Acute myeloid leukemia - M5",
        "b": "Acute myeloid leukemia - M3",
        "c": "Acute myeloid leukemia - M6",
        "d": "Acute myeloid leukemia - M2"
      },
      "correct_answer": "a",
      "explanation": "The given image shows leukemia cutis. It is seen in acute myeloid leukemia - M4 and acute \nmyeloid leukemia - M5. It refers to leukemic cells infiltrating the skin. Signs and symptoms related to the involvement of tissues other than the marrow are usually less \nstriking in AML than in acute lymphocytic leukemia (ALL). But tumors with monocytic \ndifferentiation (AML M4, M5) often infiltrate the skin (leukemia cutis) and the gingiva. This \nprobably reflects the normal tendency of monocytes to extravasate into tissues. 478 \nSold by @itachibot",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpathology/Acute_Myeloid_Leukemia__AML_Q15_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 16,
      "question": "Question 16: A 38-year-old man presents with bleeding gums for 20 days. He has gingival hyperplasia, \nhepatosplenomegaly, and lymphadenopathy. Investigations done are given below. Bone \nmarrow biopsy shows 100% cellularity with many blasts cells that are peroxidase negative \nand non-specific esterase positive. What is the most likely diagnosis?",
      "options": {
        "a": "Acute myeloid leukemia - M2",
        "b": "Acute myeloid leukemia - M0",
        "c": "Acute myeloid leukemia - M5",
        "d": "Acute myeloid leukemia - M7"
      },
      "correct_answer": "c",
      "explanation": "The given clinical scenario is suggestive of acute myeloid leukemia-M5 (AML-M5) or acute \nmonocytic leukemia. The patients with AML - M5 develop organomegaly, lymphadenopathy, gingival hyperplasia, C•S \ninvolvement, and other tissue infiltration. The bone marrow aspirate shows 20% or more \nblasts. Monoblasts have folded or lobulated nuclei, lack Auer rods, and are nonspecific esterase \npositive. Myeloperoxidase is present in the azurophilic granules of neutrophils and their precursors. It is \npositive in AML M1, M2, M3, M4 and negative in AML M0. Monoblasts and monocytes may be \nnegative or positive. When positive, the granules are smaller than in neutrophils and diffusely \nscattered throughout the cytoplasm. The image given below shows bone marrow aspirate in AML - M5.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 17,
      "question": "Question 17: A child presents with bilateral proptosis. After evaluation, he is diagnosed with chloroma. \nWhich of the following is not a marker for this condition?",
      "options": {
        "a": "Lysozyme",
        "b": "CD43",
        "c": "CD45",
        "d": "CD61"
      },
      "correct_answer": "d",
      "explanation": "CD61 is a marker of acute megakaryoblastic leukemia, not chloroma. Lysozyme, CD43, CD45, \nCD117, and MPO are positive markers of chloroma. Chloroma, also called myeloid sarcoma, granulocytic sarcoma, or myeloblastoma is an \nextramedullary tumor that occurs in 2% to 14% of patients with AML. Frequent sites of \ninvolvement are: • Skin • Lymph nodes • Gastrointestinal tract 479 \nSold by @itachibot • Bone • Soft tissue, testis • Peritoneum Orbital involvement of myeloid sarcoma is rare without any evidence of systemic \ninvolvement. Proptosis is the most common presentation. Other symptoms include lacrimal \nswelling, conjunctival mass lesion, retinal hemorrhages, ptosis, dystopia. Decreased visual acuity \nand ocular movement restriction have also been reported.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 18,
      "question": "Question 18: In which of the following conditions are Arbiskov cells seen?",
      "options": {
        "a": "Leukemia cutis",
        "b": "Myeloblastoma",
        "c": "Di Guglielmo disease",
        "d": "Richter's syndrome"
      },
      "correct_answer": "b",
      "explanation": "Arbiskov cells are monocytes seen in myeloblastoma or chloroma. Chloroma, also known as granulocytic sarcoma, is a hematopoietic stem cell tumor, \nwhere myeloblasts are located at extramedullary sites. Orbit is one of the most common sites of \noccurrences in pediatric population. It is seen in AML - M2 most commonly. Other conditions \nassociated are myelodysplastic and myeloproliferative syndromes. The image given below shows Arbiskov cells in chloroma.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 19,
      "question": "Question 19: All-trans retinoic acid is used in the treatment of tumor that is associated with which of the \nfollowing genetic aberrations?",
      "options": {
        "a": "PML-RARA",
        "b": "BCR ABL",
        "c": "cMYC",
        "d": "RŽ•X1 ETO"
      },
      "correct_answer": "a",
      "explanation": "All-trans retinoic acid (ATRA) is used in the treatment of acute promyelocytic leukemia (APML), \nwhich is associated with PML-RARA fusion gene. Acute promyelocytic leukemia (APML) is associated with a reciprocal translocation between \nchromosomes 15 and 17 producing a PML-RARA fusion gene. This fusion gene encodes for a \nchimeric protein, which consists of a part of the PML protein and a part of the retinoic acid \nreceptor- (RAR). 480 \nSold by @itachibot The normal RAR binds to the D•A and activates the transcription in the presence of retinoids. \nHowever, the chimeric protein produced by PML-RARA has reduced affinity for retinoids. This \ncauses inhibition of transcription, thereby preventing gene expression for cellular differentiation. \nThis leads to the accumulation of myeloid progenitor cells. The condition is treated with all-trans retinoic acid. It binds to the PML-RARA chimeric protein. \nThis causes conformational change such that the protein regains its normal function and activates \nD•A transcription.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 20,
      "question": "Question 20: Which of the following cytogenetic changes suggest a favorable prognosis in patients with \nacute myeloid leukemia?",
      "options": {
        "a": "t (11q23;v) with diverse MLL fusion genes",
        "b": "•ormal karyotyping with mutated •PM",
        "c": "Activating mutations in FLT3",
        "d": "Inversion (3)"
      },
      "correct_answer": "b",
      "explanation": "•ormal karyotyping with mutated •PM indicates a favorable prognosis in acute myeloid leukemia \n(AML).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    },
    {
      "q_no": 21,
      "question": "Question 21: Which among the following patients with acute myeloid leukemia has a good prognosis?",
      "options": {
        "a": "REL",
        "b": "RET",
        "c": "NF- B",
        "d": "TNFAIP3"
      },
      "correct_answer": "d",
      "explanation": "Inversion 16 is associated with a good prognosis in acute myeloid leukemia (AML). 481 \nSold by @itachibot Hodgkin's Lymphoma",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxpathology/Acute_Myeloid_Leukemia__AML_Q21_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Acute Myeloid Leukemia  AML"
    }
  ]
}
